Literature DB >> 15530850

The von Hippel-Lindau tumor suppressor protein influences microtubule dynamics at the cell periphery.

Martijn P Lolkema1, Niven Mehra, Anita S Jorna, Moniek van Beest, Rachel H Giles, Emile E Voest.   

Abstract

The von Hippel-Lindau (VHL) protein protects microtubules (MTs) from destabilization by nocodazole treatment. Based on this fixed-cell assay with static end points, VHL has been reported to directly stabilize the MT cytoskeleton. To investigate the dynamic changes in MTs induced by VHL in living cells, we measured the influence of VHL on tubulin turnover using fluorescence recovery after photobleaching (FRAP). To this end, we engineered VHL-deficient renal cell carcinoma cells to constitutively incorporate fluorescently labeled tubulin and to inducibly express VHL. Induction of VHL in these cells resulted in a decrease of tubulin turnover as measured by FRAP at the cell periphery, while minimally influencing MT dynamics around the centrosome. Our data indicates that VHL changes the behavior of MTs dependent on their subcellular localization implying a role for VHL in cellular processes such as migration, polarization, and cell-cell interactions. Here we propose a complementary method to directly measure VHL-induced subcellular changes in microtubule dynamics, which may serve as a tool to study the effect of MT binding proteins such as VHL.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530850     DOI: 10.1016/j.yexcr.2004.07.016

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  17 in total

1.  Drosophila VHL tumor-suppressor gene regulates epithelial morphogenesis by promoting microtubule and aPKC stability.

Authors:  Serena Duchi; Luca Fagnocchi; Valeria Cavaliere; Anita Hsouna; Giuseppe Gargiulo; Tien Hsu
Journal:  Development       Date:  2010-05       Impact factor: 6.868

2.  Von Hippel-Lindau gene product directs cytokinesis: a new tumor suppressor function.

Authors:  Sutapa Sinha; Gourish Mondal; Eun Ju Hwang; Da Woon Han; Shamit K Dutta; Seethalakshmi Iyer; S Ananth Karumanchi; Keun Il Kim; Fergus J Couch; Debabrata Mukhopadhyay
Journal:  J Cell Sci       Date:  2011-06-07       Impact factor: 5.285

3.  Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways.

Authors:  Jian Wu; Yuchen Jiao; Marco Dal Molin; Anirban Maitra; Roeland F de Wilde; Laura D Wood; James R Eshleman; Michael G Goggins; Christopher L Wolfgang; Marcia I Canto; Richard D Schulick; Barish H Edil; Michael A Choti; Volkan Adsay; David S Klimstra; G Johan A Offerhaus; Alison P Klein; Levy Kopelovich; Hannah Carter; Rachel Karchin; Peter J Allen; C Max Schmidt; Yoshiki Naito; Luis A Diaz; Kenneth W Kinzler; Nickolas Papadopoulos; Ralph H Hruban; Bert Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-08       Impact factor: 11.205

4.  βIII-tubulin overexpression is linked to aggressive tumor features and shortened survival in clear cell renal cell carcinoma.

Authors:  Alexander Quaas; Amir-Hossein Rahvar; Christoph Burdelski; Christina Koop; Christian Eichelberg; Michael Rink; Roland Dahlem; Thorsten Schlomm; Maria Christina Tsourlakis; Ronald Simon; Sarah Minner; Guido Sauter; Stefan Steurer
Journal:  World J Urol       Date:  2014-12-21       Impact factor: 4.226

5.  Tumor suppressor NF2/Merlin is a microtubule stabilizer.

Authors:  Zlatko Smole; Claudio R Thoma; Kathryn T Applegate; Maria Duda; Katrin L Gutbrodt; Gaudenz Danuser; Wilhelm Krek
Journal:  Cancer Res       Date:  2013-11-26       Impact factor: 12.701

6.  Novel insights into the role of the tumor suppressor von Hippel Lindau in cellular differentiation, ciliary biology, and cyst repression.

Authors:  Michael S Wiesener; Patrick H Maxwell; Kai-Uwe Eckardt
Journal:  J Mol Med (Berl)       Date:  2009-07-24       Impact factor: 4.599

Review 7.  Building it up and taking it down: the regulation of vertebrate ciliogenesis.

Authors:  Nicole Santos; Jeremy F Reiter
Journal:  Dev Dyn       Date:  2008-08       Impact factor: 3.780

8.  A University of Chicago consortium phase II trial of SB-715992 in advanced renal cell cancer.

Authors:  Richard T Lee; Kathleen E Beekman; Maha Hussain; Nancy B Davis; Joseph I Clark; Sachdev P Thomas; Katherine F Nichols; Walter M Stadler
Journal:  Clin Genitourin Cancer       Date:  2008-03       Impact factor: 2.872

Review 9.  Renal involvement in tuberous sclerosis complex and von Hippel-Lindau disease: shared disease mechanisms?

Authors:  Brian J Siroky; Maria F Czyzyk-Krzeska; John J Bissler
Journal:  Nat Clin Pract Nephrol       Date:  2009-03

10.  Von Hippel-Lindau tumor suppressor (VHL) stimulates TOR signaling by interacting with phosphoinositide 3-kinase (PI3K).

Authors:  Sun-Hong Hwang; Sunhoe Bang; Wonho Kim; Jongkyeong Chung
Journal:  J Biol Chem       Date:  2020-01-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.